Live tracker of the lag from first approval to real availability in every country
A drug approved in the US may take five years to reach a patient in Poland or never reach Nigeria. A live public tracker would show exactly where and why it is stuck.
EFPIA's W.A.I.T. indicator covers Europe annually; nothing comparable exists for Asia, Latin America or Africa, and none tracks the steps between approval and reimbursed availability. The proposal is an automated, open tracker that ingests regulatory decisions, HTA outcomes and reimbursement lists for every oncology drug in at least 60 countries and shows the stage at which each drug is stalled: not filed, under review, approved but not reimbursed, reimbursed with restrictions.
- Regulatory divergence between regions · Regulatory divergence means a drug approved in one country can take years to reach another, or never arrive.
- Most of the world has almost no cancer care · Seven in ten cancer deaths happen in low- and middle-income countries, where radiotherapy, pathology, surgery and drugs are scarce.
Pages like this
not linked directly; found by shared links- IdeaTurn Project Orbis into a work-sharing review with one shared assessment report
Shares FDA Oncology Approvals (OCE) & Novel Drug Approvals, Regulatory divergence between regions.
- IdeaA public index of how the same cancer drug's label differs between countries
Shares FDA Oncology Approvals (OCE) & Novel Drug Approvals, Regulatory divergence between regions.
- IdeaPublish every complete response letter and negative opinion across all regulators
Shares FDA Oncology Approvals (OCE) & Novel Drug Approvals, Regulatory divergence between regions.
- IdeaFund an oncology joint assessment unit inside the African Medicines Agency
Shares Regulatory divergence between regions, Most of the world has almost no cancer care.
- Idea90-day reliance approval for cancer drugs cleared by two stringent regulators
Shares Regulatory divergence between regions, Most of the world has almost no cancer care.
- IdeaConditional approvals that lapse automatically if the confirmatory trial is late
Shares FDA Oncology Approvals (OCE) & Novel Drug Approvals, Regulatory divergence between regions.
- IdeaOne clinical trial application accepted by regulators in every major region
Shares ClinicalTrials.gov, Regulatory divergence between regions.
- IdeaOne ethics approval and one consent form for a platform trial across countries
Shares ClinicalTrials.gov, Regulatory divergence between regions.